Partner Headlines - ANTH

  1. Benzinga's Top #PreMarket Gainers

    Benzinga
  2. Morning Market Gainers

    Benzinga
  3. Benzinga's Top Upgrades

    Benzinga
  4. Citigroup Upgrades Anthera Pharmaceuticals To Neutral

    Benzinga
  5. Benzinga's Top #PreMarket Gainers

    Benzinga
  6. Morning Market Gainers

    Benzinga
  7. Anthera Pharmaceuticals Announces Update On Strategic Partnership ...

    Benzinga
  8. Stocks Hitting 52-Week Lows

    Benzinga
  9. Benzinga's Top #PreMarket Gainers

    Benzinga
  10. Anthera Pharmaceuticals Announces Acquisition of Sollpura For ...

    Benzinga
  11. Hansen Medical Announces Appointment of Chris Lowe as Interim ...

    Benzinga
  12. Anthera Pharmaceuticals Accused of Withholding Data

    Benzinga
  13. Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  14. Benzinga's Microcap Movers for Monday September 17, 2012

    Benzinga
  15. Benzinga's Microcap Movers for Friday August 24, 2012

    Benzinga
  16. Anthera Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  17. Anthera Pharmaceuticals Announces Pricing of Public Offering ...

    Benzinga
  18. Benzinga's Microcap Movers for Wednesday July 18, 2012

    Benzinga
  19. Anthera Pharmaceuticals Announces Proposed Public Offering of ...

    Benzinga
  20. Benzinga's Microcap Movers for Tuesday July 17, 2012

    Benzinga
  21. Benzinga's Microcap Movers for Monday July 16, 2012

    Benzinga
  22. Anthera Pharmaceuticals Provides Additional Data from the Recently ...

    Benzinga
  23. Anthera Pharmaceuticals Inc. (ANTH) CEO Paul F Truex buys 20, ...

    GuruFocus
  24. ProShares Trust Ultra VIX Short Term Futures ETF, Nokia Corporation ...

    FoxBusiness
  25. Health Care Sector Wrap

    FoxBusiness
  26. Anthera Pharmaceuticals Down 65% After Reporting Phase 2b PEARL-SC ...

    Benzinga
  27. Benzinga's Top Downgrades

    Benzinga
  28. Anthera Updates Phase 3 Plans

    Benzinga
  29. Benzinga's Microcap Movers for Friday June 15, 2012

    Benzinga
  30. Stock Futures Little Changed Ahead of Data with Morgan Stanley ...

    MarketIntelligenceCenter
  31. UPDATE: Summer Street Research Partners Initiates Buy, $15 PT ...

    Benzinga
  32. Morning Social Media Outlook for Wednesday Feb 22

    Benzinga
  33. Anthera Pharmaceuticals Inc. (ANTH) President and CEO Paul F ...

    GuruFocus
  34. Anthera Announces Completion of Safety Review by DSMB for VISTA-16

    Benzinga
  35. UPDATE: Canaccord Initiates Buy, $13 Target on Anthera Pharmaceuticals

    Benzinga
  36. Canaccord Initiates Anthera Pharmaceuticals at Buy, $13 PT

    Benzinga
Trading Center